- Home
- CBLL vs TLRY Comparison
CBLL vs TLRY Comparison
Compare CBLL & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBLL
- TLRY
- Stock Information
- Founded
- CBLL 2014
- TLRY N/A
- Country
- CBLL United States
- TLRY Canada
- Employees
- CBLL N/A
- TLRY N/A
- Industry
- CBLL
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- CBLL
- TLRY Health Care
- Exchange
- CBLL Nasdaq
- TLRY Nasdaq
- Market Cap
- CBLL 698.0M
- TLRY 637.2M
- IPO Year
- CBLL 2024
- TLRY 2018
- Fundamental
- Price
- CBLL $14.85
- TLRY $0.45
- Analyst Decision
- CBLL Strong Buy
- TLRY Hold
- Analyst Count
- CBLL 6
- TLRY 4
- Target Price
- CBLL $33.00
- TLRY $1.58
- AVG Volume (30 Days)
- CBLL 372.9K
- TLRY 26.1M
- Earning Date
- CBLL 05-14-2025
- TLRY 04-08-2025
- Dividend Yield
- CBLL N/A
- TLRY N/A
- EPS Growth
- CBLL N/A
- TLRY N/A
- EPS
- CBLL N/A
- TLRY N/A
- Revenue
- CBLL $65,444,000.00
- TLRY $826,656,000.00
- Revenue This Year
- CBLL $30.48
- TLRY $11.80
- Revenue Next Year
- CBLL $29.52
- TLRY $5.41
- P/E Ratio
- CBLL N/A
- TLRY N/A
- Revenue Growth
- CBLL 44.71
- TLRY 11.22
- 52 Week Low
- CBLL $10.01
- TLRY $0.43
- 52 Week High
- CBLL $32.75
- TLRY $2.52
- Technical
- Relative Strength Index (RSI)
- CBLL N/A
- TLRY 29.90
- Support Level
- CBLL N/A
- TLRY $0.46
- Resistance Level
- CBLL N/A
- TLRY $0.52
- Average True Range (ATR)
- CBLL 0.00
- TLRY 0.05
- MACD
- CBLL 0.00
- TLRY -0.01
- Stochastic Oscillator
- CBLL 0.00
- TLRY 8.33
About CBLL CeriBell Inc. Common Stock
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.